MIRA INFORM REPORT
|
Report Date : |
13.05.2013 |
IDENTIFICATION DETAILS
|
Name : |
TRANSO - PHARM HANDELS - GMBH |
|
|
|
|
Registered Office : |
Bultbek 5, Siek, 22962 |
|
|
|
|
Country : |
Germany |
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
29.10.1987 |
|
|
|
|
Com. Reg. No.: |
4750AH |
|
|
|
|
Legal Form : |
Private Subsidiary |
|
|
|
|
Line of Business : |
wholesaler of
industrial chemicals |
|
|
|
|
No. of Employees : |
25 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow but Correct |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Germany |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
germany ECONOMIC OVERVIEW
The German economy - the fifth largest economy in the world in PPP
terms and Europe's largest - is a leading exporter of machinery, vehicles,
chemicals, and household equipment and benefits from a highly skilled labor
force. Like its Western European neighbors, Germany faces significant
demographic challenges to sustained long-term growth. Low fertility rates and
declining net immigration are increasing pressure on the country's social
welfare system and necessitate structural reforms. Reforms launched by the
government of Chancellor Gerhard SCHROEDER (1998-2005), deemed necessary to
address chronically high unemployment and low average growth, contributed to
strong growth in 2006 and 2007 and falling unemployment. These advances, as
well as a government subsidized, reduced working hour scheme, help explain the
relatively modest increase in unemployment during the 2008-09 recession - the
deepest since World War II - and its decrease to 6.5% in 2012. GDP contracted
5.1% in 2009 but grew by 4.2% in 2010, and 3.0% in 2011, before dipping to 0.7%
in 2012 - a reflection of low investment spending due to crisis-induced
uncertainty and the decreased demand for German exports from recession-stricken
periphery countries. Stimulus and stabilization efforts initiated in 2008 and
2009 and tax cuts introduced in Chancellor Angela MERKEL's second term increased
Germany's total budget deficit - including federal, state, and municipal - to
4.1% in 2010, but slower spending and higher tax revenues reduced the deficit
to 0.8% in 2011. In 2012 Germany reached a budget surplus of 0.1%. A
constitutional amendment approved in 2009 limits the federal government to
structural deficits of no more than 0.35% of GDP per annum as of 2016 though
the target was already reached in 2012. By 2014, the federal government wants
to balance its budget. Following the March 2011 Fukushima nuclear disaster,
Chancellor Angela Merkel announced in May 2011 that eight of the country's 17
nuclear reactors would be shut down immediately and the remaining plants would
close by 2022. Germany hopes to replace nuclear power with renewable energy.
Before the shutdown of the eight reactors, Germany relied on nuclear power for
23% of its electricity generating capacity and 46% of its base-load electricity
production.
|
Source : CIA |
Company name & address
TRANSO - PHARM
HANDELS - GMBH
Bultbek 5
Siek, 22962
Germany
Tel: +49 (0) 4107 87780
Fax: +49 (0) 4107 8778100
Synthesis
Employees: 25
Company Type: Private Subsidiary
Corporate Family: 3
Companies
Ultimate Parent: Transo-Pharm
Holding-AG
Incorporation Date:
29-Oct-1987
Financials in: USD
(Millions)
Fiscal Year End:
31-Dec-2011
Reporting Currency: Euro
Annual Sales: 18.3
Total Assets: 5.6
Business Description
TRANSO - PHARM HANDELS - GMBH is primarily engaged in wholesale of industrial chemicals (aniline, printing ink, essential oils, industrial gases, chemical glues, colouring matter, synthetic resin, methanol, paraffin, scents and flavourings, soda, industrial salt, acids and sulphur, starch derivatives, etc.); wholesale of fertilisers and agro-chemical products; wholesale of plastic materials in primary forms; and wholesale of rubber.
Industry
Industry Chemical Manufacturing
ANZSIC 2006: 3323 - Industrial
and Agricultural Chemical Product Wholesaling
NACE 2002: 5155 - Wholesale
of chemical products
NAICS 2002: 4246 - Chemical
and Allied Products Merchant Wholesalers
UK SIC 2003: 5155 - Wholesale
of chemical products
UK SIC 2007: 4675 - Wholesale
of chemical products
US SIC 1987: 5169 - Chemicals
and Allied Products, Not Elsewhere Classified
Key Executives
Name Title
Justus Dehio Managing director
Frank Krause Managing director
Philipp Titulski Managing
director
1 - Profit & Loss Item Exchange Rate: USD 1 = EUR 0.7191895
2 - Balance Sheet Item Exchange Rate: USD 1 = EUR 0.770327
Corporate Overview
Location
Bultbek 5
Siek, 22962
Germany
Tel: +49 (0) 4107 87780
Fax: +49 (0) 4107 8778100
Sales EUR(mil): 13.1
Assets EUR(mil): 4.3
Employees: 25
Fiscal Year End: 31-Dec-2011
Industry: Chemical
Manufacturing
Incorporation Date: 29-Oct-1987
Company Type: Private
Subsidiary
Quoted Status: Not
Quoted
Registered No.(DEU): 4750AH
Managing director: Justus
Dehio
Industry Codes
ANZSIC 2006 Codes:
3323 - Industrial and Agricultural Chemical Product Wholesaling
5309 - Other Warehousing and Storage Services
6240 - Financial Asset Investing
NACE 2002 Codes:
5155 - Wholesale of chemical products
6523 - Other financial intermediation not elsewhere classified
6312 - Storage and warehousing
NAICS 2002 Codes:
4246 - Chemical and Allied Products Merchant Wholesalers
5259 - Other Investment Pools and Funds
493 - Warehousing and Storage
US SIC 1987:
5169 - Chemicals and Allied Products, Not Elsewhere Classified
67 - Holding and Other Investment Offices
4225 - General Warehousing and Storage
UK SIC 2003:
5155 - Wholesale of chemical products
6523 - Other financial intermediation not elsewhere classified
6312 - Storage and warehousing
UK SIC 2007:
4675 - Wholesale of chemical products
5210 - Warehousing and storage
6499 - Other financial service activities, except insurance and
pension funding, n.e.c.
Business
Description
TRANSO - PHARM HANDELS - GMBH is primarily engaged in wholesale of industrial chemicals (aniline, printing ink, essential oils, industrial gases, chemical glues, colouring matter, synthetic resin, methanol, paraffin, scents and flavourings, soda, industrial salt, acids and sulphur, starch derivatives, etc.); wholesale of fertilisers and agro-chemical products; wholesale of plastic materials in primary forms; and wholesale of rubber.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Corporate Family |
Corporate
Structure News: |
|
|
Transo-Pharm
Holding-AG |
|
TRANSO - PHARM HANDELS - GMBH |
|
|
|
|
|
Company Name |
Company
Type |
Location |
Country |
Industry |
Sales |
Employees |
|
|
Transo-Pharm Holding-AG |
Parent |
Siek, Schleswig-Holstein |
Germany |
Commercial Banks |
32.3 |
|
|
|
TRANSO - PHARM HANDELS - GMBH |
Subsidiary |
Siek, Schleswig-Holstein |
Germany |
Chemical Manufacturing |
18.3 |
25 |
|
|
Chemex Hamburg GmbH |
Subsidiary |
Siek, Schleswig-Holstein |
Germany |
Chemical Manufacturing |
7.2 |
2 |
|
Executive report
|
Executives |
|
|
|
|
|||
|
Managing director |
Managing Director |
|
|||
|
Managing director |
Managing Director |
|
|||
|
Managing director |
Managing Director |
|
Annual Profit & Loss
|
|
31-Dec-2011 |
31-Dec-2010 |
31-Dec-2009 |
|
Period Length |
12 Months |
12 Months |
12 Months |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate
(Period Average) |
0.71919 |
0.755078 |
0.719047 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Total income |
18.3 |
17.4 |
16.5 |
|
Raw materials and services |
15.2 |
- |
- |
|
Net sales |
18.3 |
17.4 |
16.5 |
|
Other operating income |
0.8 |
0.5 |
1.1 |
|
Raw materials and consumables employed |
15.2 |
- |
- |
|
Other external charges |
0.2 |
- |
- |
|
Cost of goods sold |
15.4 |
14.1 |
13.9 |
|
Cost of raw materials |
15.4 |
14.1 |
13.9 |
|
Taxes and social security costs |
0.3 |
- |
- |
|
Total payroll costs |
2.0 |
1.8 |
1.9 |
|
Cost of stock depreciation and
amortisation |
0.0 |
- |
- |
|
Fixed asset depreciation and amortisation |
0.1 |
0.2 |
0.1 |
|
Other operating costs |
1.2 |
1.2 |
1.3 |
|
Net operating
income |
0.4 |
0.5 |
0.4 |
|
Other income |
0.2 |
0.3 |
0.5 |
|
Interest payable on loans |
0.3 |
0.2 |
0.3 |
|
Total expenses |
0.0 |
-0.1 |
-0.3 |
|
Profit before tax |
0.3 |
0.6 |
0.7 |
|
Extraordinary income |
0.1 |
- |
- |
|
Provisions |
0.9 |
0.7 |
0.7 |
|
Extraordinary expenses |
- |
0.2 |
0.1 |
|
Extraordinary result |
0.1 |
-0.2 |
-0.1 |
|
Total taxation |
0.0 |
0.0 |
0.0 |
|
Net profit |
0.4 |
0.3 |
0.5 |
Annual Balance Sheet
Financials in: USD (mil)
|
|
31-Dec-2011 |
31-Dec-2010 |
31-Dec-2009 |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate |
0.770327 |
0.745406 |
0.696986 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Issued capital |
0.5 |
0.5 |
0.6 |
|
Profits for the year |
0.5 |
0.1 |
0.4 |
|
Profit brought forward from previous
year(s) |
0.1 |
- |
-0.1 |
|
Total
stockholders equity |
1.0 |
0.7 |
1.0 |
|
Deferred taxation |
0.0 |
0.0 |
0.0 |
|
Other provisions |
0.3 |
0.2 |
0.2 |
|
Provision for pensions |
0.5 |
0.5 |
0.5 |
|
Provisions and allowances |
0.8 |
0.7 |
0.7 |
|
Trade creditors |
1.8 |
2.0 |
3.3 |
|
Advances received |
0.0 |
0.1 |
0.0 |
|
Other loans |
0.5 |
0.7 |
0.0 |
|
Taxation and social security |
1.4 |
0.0 |
0.0 |
|
Due to group companies |
0.0 |
1.6 |
2.0 |
|
Total current
liabilities |
3.8 |
4.4 |
5.3 |
|
Total
liabilities (including net worth) |
5.6 |
5.8 |
7.1 |
|
Patents |
0.0 |
0.0 |
0.0 |
|
Intangibles |
0.0 |
0.0 |
0.0 |
|
Total tangible
fixed assets |
0.2 |
0.3 |
0.3 |
|
Long-term investments |
0.1 |
0.1 |
0.1 |
|
Shares held in associated companies |
0.0 |
0.0 |
0.0 |
|
Total financial
assets |
0.2 |
0.2 |
0.2 |
|
Total
non-current assets |
0.4 |
0.4 |
0.5 |
|
Finished goods |
1.0 |
1.3 |
1.3 |
|
Net stocks and work in progress |
1.0 |
1.3 |
1.3 |
|
Trade debtors |
2.1 |
3.4 |
4.4 |
|
Other receivables |
0.4 |
0.5 |
0.7 |
|
Total
receivables |
4.2 |
4.0 |
5.2 |
|
Owing from associated companies |
0.8 |
0.1 |
0.1 |
|
Cash and liquid assets |
0.0 |
0.0 |
0.0 |
|
Total current
assets |
5.2 |
5.3 |
6.6 |
|
Prepaid expenses and deferred costs |
0.0 |
0.0 |
0.0 |
|
Total assets |
5.6 |
5.8 |
7.1 |
Annual Ratios
Financials in: USD (mil)
|
|
31-Dec-2011 |
31-Dec-2010 |
31-Dec-2009 |
|
Period Length |
12 Months |
12 Months |
12 Months |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate |
0.770327 |
0.745406 |
0.696986 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Current ratio |
13.74 |
12.14 |
12.28 |
|
Acid test ratio |
11.19 |
9.22 |
9.83 |
|
Total liabilities to net worth |
0.38% |
0.66% |
0.55% |
|
Net worth to total assets |
0.02% |
0.01% |
0.01% |
|
Current liabilities to net worth |
0.38% |
0.66% |
0.55% |
|
Current liabilities to stock |
0.39% |
0.34% |
0.41% |
|
Fixed assets to net worth |
0.04% |
0.07% |
0.05% |
|
Collection period |
460.00 |
708.00 |
949.00 |
|
Stock turnover rate |
0.56 |
0.73 |
0.77 |
|
Profit margin |
0.00% |
0.00% |
0.00% |
|
Return on assets |
0.01% |
0.01% |
0.01% |
|
Shareholders' return |
0.04% |
0.05% |
0.05% |
|
Net worth |
1.0 |
0.7 |
1.0 |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.54 |
|
UK Pound |
1 |
Rs.84.19 |
|
Euro |
1 |
Rs.71.11 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.